Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets
about
Donor-Specific Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell TransplantationThe clinical application of mesenchymal stromal cells in hematopoietic stem cell transplantationHow do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?Donor Specific Anti-HLA Antibody and Risk of Graft Failure in Haploidentical Stem Cell TransplantationGuidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Donor-Specific Anti-Human Leukocyte Antigen Antibodies Predict Prolonged Isolated Thrombocytopenia and Inferior Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation.Impact of ABO incompatibility on patients' outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the Acute Leukemia Working Party of the EBMT.Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood--a report from Eurocord, the AA review of hematopoietic cell transplantation in China: data and trends during 2008-2016.Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant.Antifungal prophylaxis of patients undergoing allogenetic hematopoietic stem cell transplantation in China: a multicenter prospective observational study.Impact of Donor-Specific anti-HLA Antibodies and Donor KIR Characteristics in Haploidentical HSCT for Beta-Thalassemia.Fighting against hematological malignancy in China: from unique system to global impact.Lower incidence of acute GVHD is associated with the rapid recovery of CD4+CD25+CD45RA+ regulatory T cells in patients who received haploidentical allografts from NIMA-mismatched donors: A retrospective (development) and prospective (validation) cohWharton's Jelly Mesenchymal Stromal Cells as a Feeder Layer for the Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells: a Review.Haploidentical Related Donor Hematopoietic Stem Cell Transplantation for Dedicator-of-Cytokinesis 8 Deficiency Using Post-Transplantation Cyclophosphamide.Viral encephalitis after haplo-identical hematopoietic stem cell transplantation: Causative viral spectrum, characteristics, and risk factors.The bone marrow microenvironment is similarly impaired in allogeneic hematopoietic stem cell transplantation patients with early and late poor graft function.Prophylactic use of low-dose interleukin-2 and the clinical outcomes of hematopoietic stem cell transplantation: A randomized study.Critical updates in the 7th edition of the American Society for Apheresis guidelines.The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation.Low-dose post-transplant cyclophosphamide can mitigate GVHD and enhance the G-CSF/ATG induced GVHD protective activity and improve haploidentical transplant outcomes.Major Histocompatibility Complex and Hematopoietic Stem Cell Transplantation: Beyond the Classical HLA Polymorphism.The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology.Effective desensitization of donor-specific HLA antibodies using platelet transfusion bearing targeted HLA in a case of HLA-mismatched allogeneic stem cell transplantation.Relationship of Cell Compositions in Allografts with Outcomes after Haploidentical Transplantation for Acquired Severe Aplastic Anemia: Effects of CD34 and CD14 Cell Doses
P2860
Q26738469-D9F46172-DFF9-4CE1-BFCE-C876C3304F09Q26748595-93A51486-26F8-4240-95D8-2A01BA27F7FAQ26748867-BAD27F3D-CC2B-4B7C-9709-303FE77425AAQ26767440-8B7C241F-222C-4BF8-8B6F-303E04F467CAQ30276550-790C3957-7F32-4AEF-8956-FC2F48FC6E10Q33441698-D6D7FABF-7BF1-4C9A-831D-5311C6E8AE01Q33746730-9032BCA4-0896-4AE6-9356-0DFFA32C31D6Q33868328-804993D7-622D-4B53-BF17-F8486EB6362AQ36125603-1AA9332A-98E9-4E0A-9409-94AAAD79DCD8Q36354948-B75A57D4-10CC-4822-81EB-93BDB1A92FB4Q37258220-A3E47672-9226-4F41-96C2-C2CEA4C50786Q37280740-A3B53907-123F-4E90-BBB2-8CB08AA96874Q37677242-70003703-81CA-4A1E-B57D-74FAD8CC6B16Q38632968-2B968A2D-00CF-47C2-A410-5F0D6111EDB6Q38970849-2143F7E7-3A54-48B3-8849-E4035BAF7C48Q39010662-15D4AA0D-458D-47B0-A668-94EF670FB649Q40296052-8CC68AE8-2AA4-4FCB-9B9E-319683488668Q40361692-B8553BCB-2806-4515-952A-C98CA0CC19A8Q40466615-25DDBFEE-DC7F-4445-A42C-CE4EF959E0A0Q42968779-CF099CDE-9B02-4A55-BE4B-D51897F0C9C6Q48217985-3D213F33-C2AB-4B03-BB69-C8D3022F1DD8Q50042370-E8545F59-FC7B-42CF-8CD6-5167A4FAF9A8Q51783552-94DDA5EF-C64E-412D-9653-5D3ED642758CQ52374806-CC07CB89-7A9C-4FF9-B4F3-CCF43FA76985Q52678836-F46CC04A-8CFC-486B-8FB2-8713A8ABB548Q52794502-17502A74-3DF6-45EF-9FF8-6657C1535C01Q58714339-70523EDA-F2D2-4D94-9725-CCE2B0AE6ADB
P2860
Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Donor-specific anti-human leuk ...... d training and validation sets
@ast
Donor-specific anti-human leuk ...... d training and validation sets
@en
type
label
Donor-specific anti-human leuk ...... d training and validation sets
@ast
Donor-specific anti-human leuk ...... d training and validation sets
@en
prefLabel
Donor-specific anti-human leuk ...... d training and validation sets
@ast
Donor-specific anti-human leuk ...... d training and validation sets
@en
P2093
P2860
P1476
Donor-specific anti-human leuk ...... d training and validation sets
@en
P2093
Feng-Rong Wang
Kai-Yan Liu
Lan-Ping Xu
Ming-Rui Huo
Xiang-Yu Zhao
Xiao-Dong Mo
Xiao-Hui Zhang
P2860
P2888
P356
10.1186/S13045-015-0182-9
P577
2015-07-10T00:00:00Z
P5875
P6179
1000265393